Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3

By sjmartinez • March 31, 2023

Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, Tseng CH, Li S, Cheung DS, Gofnung YA, Famini P, Wu JX, Yeh MW, Livhits MJ. Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210/clinem/dgad181. Epub ahead of print. PMID: 36995878.

Tags: Endocrinology, General Internal Medicine, indeterminate nodules, molecular testing, nonoperative, Publications, surveillance, thyroid, thyroid cancer

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE[...]

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility

Leung AM, Brent GA, Larson SM, Osborne JR, Flavell RR, Ringel MD, Sosa JA. Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility. Thyroid.[...]

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]